$1.35
+0.08 (+6.30%)
Analyst Consensus
Strong Buy
14
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+2,900.7% upside
Low Target
$28.40
Average Target
$40.51
High Target
$50.89
Current Price
$1.35
Current
$1.35
$1.35
Target
$40.51
$40.51
$28.40
$40.51 avg
$50.89
Scenario Analysis
Bear Case
$28.40
2,003.7%
Low target
Base Case
$40.51
+2,900.7%
Avg target
Bull Case
$50.89
+3,669.6%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$40.49
-96.7% from high
52-Week Low
$25.27
+-94.7% from low
Target vs 52W High
$40.51
+0.0% vs high
Next Earnings Report
Feb 25, 2026 · After Market Close
9d
until earnings
EPS Est: $-0.68
Earnings in 9 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Buy | 37 | 68% | $257.58 | +15.3% |
| AMGN | Hold | 41 | 54% | $190.87 | -50.3% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +137.8% |
| VRTX | Strong Buy | 39 | 77% | $438.34 | -8.3% |
| REGN | Strong Buy | 36 | 75% | $76.80 | -90.2% |
| ALNY | Strong Buy | 36 | 75% | $102.31 | -68.8% |
| INSM | Strong Buy | 27 | 93% | $143.40 | -4.3% |
| BIIB | Hold | 42 | 48% | $91.45 | -54.5% |